Form 4 for NRXP NRX Pharmaceuticals, Inc.

Accepted 2021-11-02 00:00:00 ET · period of report 2021-07-16 · accession 0000950142-21-003505 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2021-11-02	2021-07-16	NRXP	Javitt Daniel C.	10%	G - Gift	—	-869.2K	13.10M	-6%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-07-16	G	D	434,594	—	13,537,270	I By Glytech LLC	—	—	(F1) Irrevocable gift by way of transfer to certain trusts established for the benefit of the Reporting Person's immediate family members. Neither the Reporting Person nor Glytech LLC received any compensation in respect of such transfers. Upon completion of such transfers, both the Reporting Person and Glytech LLC ceased to have any beneficial ownership or other interest in the shares subject to the transfers. (F2) Held by Glytech, LLC of which the Reporting Person is the sole owner.
2	Common	Common Stock	2021-07-16	G	D	434,594	—	13,102,676	I By Glytech LLC	—	—	(F1) Irrevocable gift by way of transfer to certain trusts established for the benefit of the Reporting Person's immediate family members. Neither the Reporting Person nor Glytech LLC received any compensation in respect of such transfers. Upon completion of such transfers, both the Reporting Person and Glytech LLC ceased to have any beneficial ownership or other interest in the shares subject to the transfers. (F2) Held by Glytech, LLC of which the Reporting Person is the sole owner.